|
Session 129
Poster Abstracts
Incidence and Risk Factors for Cardiovascular Disease
Monday, 1:30 - 3:30 pm
Poster Hall |
735
 |
Analysis of Cardiovascular Risk Factors in the HIV Outpatient Study Cohort
Kenneth Lichtenstein*1, C Armon2, K Buchacz3, A Moorman3, K Wood2, J Brooks3, and HIV Outpatient Study Group
1Univ of Colorado Hlth Sci Ctr, Denver, US; 2Cerner Corp, Vienna, VA, US; and 3CDC, Atlanta, GA, US |
| 736 |
ART and Asymptomatic Ischemic Heart Disease in HIV-infected Adults: A Cross-sectional Analysis of Patients Enrolling in the SMART Trial
Andrew Carr*1, B Grund2, J Neuhaus2, W El-Sadr3, G Grandits2, C Gibert4, J Neaton2, R Prineas5, and on behalf of the SMART Study Investigators
1St Vincent's Hosp, Sydney, Australia; 2Univ of Minnesota, Minneapolis, US; 3Harlem Hosp, Columbia Univ, New York, NY, US; 4VAMC, Washington, DC, US; and 5EPICARE, Winston-Salem, NC, US |
737
|
Hospitalizations for CHD and MI among Northern California HIV+ and HIV- Men: Changes in Practice and Framingham Risk Scores
Daniel Klein*1, L Hurley2, C Quesenberry2, M Silverberg2, M Horberg2, and S Sidney2
1Kaiser Permanente, Hayward, CA, US and 2Kaiser Permanente, Oakland, CA, US |
738
|
Long Term HIV Infection as an Independent Risk Factor for Early Atherosclerosis
Christoph Stephan*1, A Carlebach1, A Haberl1, M Bickel1, M Lorenz2, A Harmjantz2, A Buehler2, M Sitzer2, and S Staszewski1
1HIV Treatment and Res Unit and 2JW Goethe Univ Hosp, Frankfurt, Germany |
| 739 |
Predictors of Abnormal Coronary Calcification Scores at 3 Years in the Nutrition for Healthy Living Cohort Study
Jul Gerrior*1, A Tang1, J Fauntleroy1, K Hendricks1, A Mangili2, E Schaefer2, S Gorbach1, and C Wanke1
1Tufts Univ Sch of Med, Boston, MA, US and 2Tufts-New England Med Ctr, Boston, MA, US |
740
|
Predictors of Successful Blood Pressure Management in HIV-infected Patients at Moderate to High 10-year Risk of Coronary Heart Disease: The Swiss HIV Cohort Study
Heiner Bucher*1, T Glass1, R Weber2, P Vernazza3, M Rickenbach4, H Furrer5, E Bernasconi6, M Cavasini7, B Hirschel8, M Battegay9, and the Swiss HIV Cohort Study
1Basel Inst for Clin Epidemiology, Switzerland; 2Univ Hosp, Zürich, Switzerland; 3Kantonsspital St Gallen, Switzerland; 4Swiss HIV Cohort Study Data Ctr, Lausanne; 5Univ Hosp, Berne, Switzerland; 6Hosp Civico, Lugano, Switzerland; 7Ctr Univ Hosp Vaudois, Lausanne, Switzerland; 8Geneva Univ Hosp, Switzerland; and 9Univ Hosp, Basel, Switzerland |
| 741 |
Increased Carotid Intima-media Thickness in HIV-infected Patients Is Associated with Increased C-reactive Protein Levels and Increased Cytomegalovirus Specific T Cell Activation
Priscilla Hsue*1,2, P Hunt1,2, D Waters1,2, E Sinclair3, J Martin1,2, A Franklin2, R Hoh1,2, and S Deeks1,2
1Univ of California, San Francisco, US; 2San Francisco Gen Hosp Med Ctr, CA, US; and 3Gladstone Inst of Virology and Immunology, Univ of California, San Francisco, US |
| 742 |
The Effect of Lopinavir-Ritonavir ( LPVr) on Endothelial Function in Healthy Volunteers
Jessica Grubb*1, A Dejam2, J Voell1, W Blackwelder3, P Sklar3, J Kovacs3, R Cannon4, M Gladwin4, and H Masur3
1NIAID, NIH, DHHS, Bethesda, MD, US; 2Natl Inst of Diabetes and Digestive and Kidney Diseases, NIH, DHHS, Bethesda, MD, US; 3Clin Ctr, NIH, DHHS, Bethesda, MD, US; and 4Natl Heart, Lung, and Blood Inst, NIH, DHHS, Bethesda, MD, US |
| 743 |
HIV is Associated with Pulmonary Hypertension Independent of Known Risk Factors
Priscilla Hsue*1,2, D Waters1,2, H Farah1,2, A Bolger1,2, S Palav1, L Huang1,2, S Deeks1,2, A Ellman2, S Dollard3, and J Martin1,2
1San Francisco Gen Hosp Med Ctr, CA, US; 2Univ of California, San Francisco, US; and 3CDC, Atlanta, GA, US |
744
|
Prevalence of Pulmonary Arterial Hypertension in HIV Positive Outpatients in the HAART Era
Daniel Sereni*1, O Sitbon2, C Lascoux-Combe1, F Raffi3, G Pialoux4, P Yeni5, V Gressin6, P Clerson7, J F Delfraissy8, and G Simonneau2
1Hosp Saint Louis, Paris, France; 2Hosp A Béclère, Clamart, France; 3Unité de Recherche VIH, Nantes, France; 4Hosp Tenon, Paris, France; 5Hosp Bichat, Paris, France; 6Actelion Pharma, Paris, France; 7Orgamétrie, Roubaix, France; and 8Hosp Bicêtre, Le Kremlin Bicêtre, France |
745
|
Long-term Safety Profile of Bosentan in Patients with Pulmonary Arterial Hypertension Associated with HIV: Results from the Tracleer PMS Database
M Humbert1, M Hoeper2, D Kiely3, Eleanor Segal*4, and J Carlsen5
1Hosp Antoine Beclere, Clamart, France; 2Hannover Med Sch, Germany; 3Royal Hallamshire Hosp, Sheffield, UK; 4Actelion Pharma, Allschwil, Switzerland; and 5Rigshospitalet, Copenhagen, Denmark |
|
